Micafungin concentrations from brain tissue and pancreatic pseudocyst fluid.

Antimicrobial Agents and Chemotherapy
Asma LatJames S Lewis

Abstract

We report the attainment of micafungin concentrations from brain tissue and pancreatic pseudocyst fluid from two patients with invasive candidiasis. Micafungin was present in low levels at both body sites, indicating limited penetration into central nervous system (CNS) tissue and pancreatic fluid. Further studies are needed to fully characterize its pharmacokinetics at these locations, as micafungin may potentially serve as an alternative antifungal therapy for CNS or pancreatic candidal infections for which the currently recommended first-line therapy fails.

References

Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan J De WaeleF Colardyn
Oct 3, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph S SolomkinUNKNOWN Infectious Diseases Society of America
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Nita L SeibelThomas J Walsh
Apr 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P H Chandrasekar, J D Sobel
May 19, 2006·The New England Journal of Medicine·David C Whitcomb
Oct 13, 2006·The American Journal of Gastroenterology·Peter A BanksUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
May 8, 2007·Lancet·Ernst-Rüdiger KuseUNKNOWN Micafungin Invasive Candidiasis Working Group
Sep 7, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasDonald N Buell
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America

❮ Previous
Next ❯

Citations

Feb 1, 2012·Antimicrobial Agents and Chemotherapy·Michaela LacknerJacques F Meis
Oct 19, 2013·Expert Review of Anti-infective Therapy·Kim VanstraelenIsabel Spriet
Sep 9, 2010·Expert Opinion on Drug Metabolism & Toxicology·Effie L Kuti, Joseph L Kuti
Jan 4, 2012·The American Journal of Medicine·Dimitrios P Kontoyiannis
Jul 11, 2016·Revista iberoamericana de micología·José Ramón Azanza Perea
Oct 21, 2016·The Pediatric Infectious Disease Journal·Julie AutmizguineKevin M Watt
Jun 27, 2018·Expert Opinion on Drug Metabolism & Toxicology·Katharine E Stott, William Hope
Jan 8, 2014·Clinical Microbiology Reviews·Timothy FeltonWilliam W Hope
Jun 22, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Shannon L Holt, Richard H Drew
Mar 1, 2019·Medical Mycology·Yanan ZhaoDavid S Perlin
Apr 29, 2020·Antimicrobial Agents and Chemotherapy·Jana MarxRomuald Bellmann
Nov 6, 2018·Current Fungal Infection Reports·Rebecca A Drummond, Michail S Lionakis
Aug 10, 2017·Clinical Pharmacokinetics·Roeland E WasmannRoger J Brüggemann
Oct 17, 2019·Journal of Fungi·Elizabeth Dodds Ashley
Apr 21, 2021·Infection·Tiziana GasperettiRomuald Bellmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Kiyofumi MochizukiShinji Ogura
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Greg T SiwekMichael A Pfaller
© 2022 Meta ULC. All rights reserved